PAHO highlights increase in dengue, Oropouche, and avian influenza cases in the Americas, control measures advised
On Dec. 10, 2024, the Pan American Health Organization (PAHO) reported on three transmissible diseases affecting the Region…
-
-
Measles cases surged worldwide, infecting 10.3 million people in 2023
On Nov. 14, 2024, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention…
-
University of Illinois and Universidade de Sao Paulo develop first transgenic cow to produce human insulin in her milk
On Mar. 13, 2024, an unassuming brown bovine from the south of Brazil has made history as the…
-
Catastrophic mortality of elephant seals in Argentina Identified as outbreak of avian influenza
On Jan. 22, 2024, the University of California, Davis announced the first reported outbreak of high pathogenicity H5N1…
-
Moderna expanded global footprint through commercial partnership with Adium in Latin America
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
-
Resverlogix expanded phase 2b clinical trial for COVID-19 treatment with first site in Brazil and second in Canada
On Feb. 17, 2022, Resverlogix announced that the first Brazilian site had been initiated for its Phase 2b…
-
Mixed vaccine schedules offered strong booster responses after two doses of CoronaVac vaccine
On Jan. 24, 2022, the University of Oxford announced that a third booster dose of either the ChAdOx1…
-
Brazilian Health Regulatory Agency authorized Sorrento phase 2 clinical trial of COVI-MSC in COVID-19l long-hauler patients
On Jan. 18, 2022, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
-
INOVIO further expanded INNOVATE phase 3 trial for COVID-19 DNA vaccine candidate INO-4800 in India
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
-
INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
-
T2 Biosystems T2SARS-CoV-2 panel proved capable of detecting the Brazil P1 variant of SARS-CoV-2 virus
On Feb. 4, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detects…
-
South Carolina detected first US cases associated with variant first detected in South Africa
On Jan. 28, 2021, the CDC announced that it had become aware of the first U.S. documented cases…
-
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
On Nov. 23, 2020, AstraZeneca announced positive high-level results from an interim analysis of clinical trials of AZD1222…
-
COVISHIELD completed enrollment of phase III clinical trials under partnership of ICMR and Serum Institute
On Nov. 11, 2020, the Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) announced…
-
The CDC opened new South America Regional Office in Brazil
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
-
FDA authorised restart of the COVID-19 AZD1222 vaccine US phase III trial
On Oct. 23, 2020, AstraZeneca announced that the clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, had…
-
Ionis antisense medicine evaluated in an investigator-initiated clinical study of COVID-19 patients in Brazil
On Oct. 15, 2020, Ionis Pharmaceuticals announced that IONIS-PKK-LRx was being evaluated in an investigator-initiated Phase 2 clinical…
-
Brazilian Health Regulatory Agency authorized Sorrento’s phase 2 clinical trial of Abivertinib in COVID-19 patients
On Oct. 14, 2020, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
-
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
-
Brazil approved RedHill Biopharma’s phase 2/3 COVID-19 study with opaganib
On Sept. 22, 2020, RedHill Biopharma announced approval from the Brazilian Health Regulatory Agency (ANVISA) for its ongoing…
-
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 10, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
-
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
-
DNA evidence used to identify Josef Mengele from skeletal remains
In 1992, DNA evidence was used to identify Josef Mengele from skeletal remains. Bone DNA analysis was therefore…
-
The CDC launched a smallpox campaign in Brazil to evaluate efficacy of jet ejector equipment in the field
In 1965, the U.S. Centers for Disease Control and Prevention (CDC) launched a smallpox campaign in Anapa, Brazil…
-
Johnson ﾠ&ﾠ Johnson expanded into Argentina and Brazil
In 1937, Johnson ﾠ&ﾠ Johnson expanded into Argentina and Brazil.
-
Charles Nicolle and Louis Manceaux at the Pasteur Institute first described Toxoplasma gondii
In 1908, Charles Nicolle and Louis Manceaux at the Pasteur Institute were the first to describe Toxoplasma gondii…
